T2 Biosystems
T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel
The clearance allows the firm to immediately begin marketing an assay that simultaneously detects six biothreat pathogens directly from blood.
In Brief This Week: Labcorp; T2 Biosystem; MiRxes; Accelerate Diagnostics; and More
News items for the week of Aug. 7, 2023.
In Brief This Week: Quest Diagnostics; T2 Biosystems; OraSure Technologies; DermTech; and More
News items for the week of July 31, 2023.
In Brief This Week: AACC; Siemens Healthineers; Bio-Rad; T2 Biosystems; DermTech; More
News items for the week of July 17, 2023.
In Brief This Week: Labcorp; T2 Biosystems; Thermo Fisher Scientific; Bio-Techne; More
News items for the week of July 10, 2023.
Feb 15, 2023
T2 Biosystems Prices $12M Public Offering
Oct 14, 2022
Canaccord Downgrades T2 Biosystems to Hold
Aug 30, 2022